E-LIB Suche - Ergebnisse für: Fabi, A.

1

133P Clinico-pathological predictors of outcome in the (neo..:

Carbognin, L. ; Franco, A. ; Rossi, A....
ESMO Open. 9 (2024) - p. 103120 , 2024

Link: https://doi.org/10.1016/..

2

Intermediate clinical endpoints in early-stage breast cance..:

Blondeaux, E. ; Xie, W. ; Carmisciano, L....
European Journal of Cancer. 200 (2024) - p. 113607 , 2024

Link: https://doi.org/10.1016/..

3

154P Validation of PREDICT tool version 2.2 in early-stage ..:

Borea, R. ; Blondeaux, E. ; Carmisciano, L....
ESMO Open. 9 (2024) - p. 103141 , 2024

Link: https://doi.org/10.1016/..

4

210P Prognostic value of HER2-low status in metastatic brea..:

Molinelli, C. ; Bruzzone, M. ; Blondeaux, E....
ESMO Open. 9 (2024) - p. 103232 , 2024

Link: https://doi.org/10.1016/..

5

158TiP Neoadjuvant abemaciclib and giredestrant trial in pa..:

von Arx, C. ; Calabrese, A. ; Caputo, R....
ESMO Open. 9 (2024) - p. 103145 , 2024

Link: https://doi.org/10.1016/..

6

174P Endocrine disruptors and life STILe in patients carryi..:

Fabi, A. ; Franco, A. ; Cordisco, E. Lucci...
ESMO Open. 8 (2023) 1 - p. 101451 , 2023

Link: https://doi.org/10.1016/..

7

224P Clinical features and outcomes in HER2+ mBC patients t..:

Botticelli, A. ; Scagnoli, S. ; Pisegna, S....
ESMO Open. 8 (2023) 1 - p. 101413 , 2023

Link: https://doi.org/10.1016/..

8

138P Activity and efficacy of neoadjuvant chemotherapy (NAC..:

Garufi, G. ; Carbognin, L. ; Mastrantoni, L....
ESMO Open. 8 (2023) 1 - p. 101477 , 2023

Link: https://doi.org/10.1016/..

9

Corrigendum to "Optimizing choices and sequences in the dia..:

Miglietta, F. ; Fabi, A. ; Generali, D....
Cancer Treatment Reviews. 117 (2023) - p. 102570 , 2023

Link: https://doi.org/10.1016/..

10

KI‐67 PROLIFERATION PATTERNS ARE PREDICTIVE OF EARLY PROGRE..:

Rojek, A. E. ; Venkataraman, G. ; Fabi, L....
Hematological Oncology. 41 (2023) S2 - p. 682-683 , 2023

Link: https://doi.org/10.1002/..

11

101P Prognostic and clinical impact of the endocrine resist..:

Lambertini, M. ; Blondeaux, E. ; Bisagni, G....
ESMO Open. 8 (2023) 1 - p. 101325 , 2023

Link: https://doi.org/10.1016/..

12

Corrigendum to "Optimizing choices and sequences in the dia..:

Miglietta, F. ; Fabi, A. ; Generali, D....
Cancer Treatment Reviews. 119 (2023) - p. 102594 , 2023

Link: https://doi.org/10.1016/..

13

Optimizing choices and sequences in the diagnostic-therapeu..:

Miglietta, F. ; Fabi, A. ; Generali, D....
Cancer Treatment Reviews. 114 (2023) - p. 102511 , 2023

Link: https://doi.org/10.1016/..

14

209P Trastuzumab plus lapatinib or chemotherapy in patients..:

De Angelis, C. ; Pagliuca, M. ; Gamucci, T....
ESMO Open. 8 (2023) 1 - p. 101398 , 2023

Link: https://doi.org/10.1016/..

15

236P Trastuzumab deruxtecan in Italian real-world experienc..:

Botticelli, A. ; Pisegna, S. ; Scagnoli, S....
ESMO Open. 8 (2023) 1 - p. 101424 , 2023

Link: https://doi.org/10.1016/..